TOP STORIES

• REGULATORY Japan Launches Pilot Expert Committee System for Patent Linkage Reviews, Aims to Reduce IP Feuds
  November 17, 2025

• COMMENTARY MOF Autumn Proposals Signal a Shift from Drug Pricing to Cost-Sharing Reform
  November 17, 2025

• REGULATORY Chuikyo Split over Higher Copays under LLP Scheme; Payer Push Meets Provider Caution
  November 17, 2025

• BUSINESS Fuji Stresses No Supply Impact, Denies Patent Allegations over Eylea Biosimilar
  November 17, 2025

• REGULATORY Elrexfio to Escape CEA-Based Price Tweak, Analysis to Resume for Paxlovid
  November 17, 2025

• BUSINESS Novartis Overhauls Sales Model to Prioritize Solving Regional Treatment Gaps
  November 14, 2025

• REGULATORY Nipro-Samsung Alliance Nears First Approval in Japan with Stelara Biosimilar
  November 14, 2025

• REGULATORY Japan Panel to Review KalVista’s Oral HAE Drug, GSK’s Asthma Med, and More on Nov. 27
  November 14, 2025

• BUSINESS Keytruda Again Tops Japan Market in July-September: IQVIA
  November 14, 2025

• BUSINESS Bayer, Regeneron Move to Block Fuji’s Newly Listed Eylea Biosimilar in Japan
  November 13, 2025

• REGULATORY LDP Study Group Seeks Uniform 5% Drug Price Hike, Warns of US MFN Spillover
  November 12, 2025

• BUSINESS J&J Japan Targets Top Share in Key Disease Areas by 2030: New President
  November 12, 2025

• REGULATORY Japan’s 1st Biosimilars for Eylea, Actemra Get NHI Listing in November
  November 11, 2025

• REGULATORY MOF Pushes Stronger Use of CEA for Pricy Meds towards FY2026 Budget
  November 11, 2025

• REGULATORY Growth Strategy Council Seeks Stronger Drug Discovery Infrastructure in Economic Plan
  November 11, 2025

• COMMENTARY Japan’s Trading Houses Gain Ground in Pharma, Rewriting the Industry Playbook
  November 10, 2025

• BUSINESS MSD Japan Chief Voices Regret over Delay in Routine HPV Shots for Males
  November 10, 2025

• REGULATORY MHLW Weighs Higher Copay Ratios for LLPs; 1/2 to Full Gap on the Table
  November 7, 2025

• BUSINESS Novo Nordisk Taps Keisuke Kotani as New Japan Chief
  November 7, 2025

• REGULATORY Keytruda Faces 5th Price Cut under Special Re-Pricing; MSD Warns of Ripple Effects
  November 6, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• …
• Next ›
• 最終 »